Brookfield Corp’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-123,193
| Closed | -$3.06M | – | 485 |
|
|
2023
Q2 | $3.06M | Sell |
123,193
-375,098
| -75% | -$9.32M | 0.01% | 353 |
|
|
2023
Q1 | $7.49M | Buy |
498,291
+242,842
| +95% | +$3.65M | 0.03% | 218 |
|
|
2022
Q4 | $3.02M | Sell |
255,449
-42,394
| -14% | -$502K | 0.01% | 332 |
|
|
2022
Q3 | $1.76M | Buy |
297,843
+67,153
| +29% | +$397K | 0.01% | 468 |
|
|
2022
Q2 | $980K | Buy |
230,690
+46,897
| +26% | +$199K | ﹤0.01% | 490 |
|
|
2022
Q1 | $1.75M | Buy |
183,793
+115,484
| +169% | +$1.1M | 0.01% | 406 |
|
|
2021
Q4 | $1.3M | Buy |
68,309
+40,980
| +150% | +$779K | 0.01% | 386 |
|
|
2021
Q3 | $910K | Buy |
27,329
+8,880
| +48% | +$296K | ﹤0.01% | 422 |
|
|
2021
Q2 | $716K | Buy |
+18,449
| New | +$716K | ﹤0.01% | 478 |
|